Please assess the completion status of the following clinical trial:

Trial Title: Follow the Sutures. A New Procedure for Injection of Botulinum Toxin for Chronic Migraine

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Chronic migraine, as defined in the ICHD-3 beta version~* Chronic migraine should have been present for at least ½ year prior to evaluation for study inclusion~* For women of child-bearing potential there must be no pregnancy or planned pregnancy during the study period, and use of highly effective contraception~* Signed informed consent and expected cooperation of the patients for the treatment and follow up must be obtained and documented according to ICH GCP, and national/local regulations~Exclusion Criteria:~* Diseases that are contraindications for use of Botulinum toxin A (Myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis, other diseases interfering with neuromuscular function)~* Allergy to Botulinum toxin A~* Other primary or secondary headache disorder, including medication overuse headache (MOH). This means that at least one attempt to withdraw acute medication should have been performed earlier, but without success~* Severe depression or other psychiatric disorder that may interfere with the treatment~* Abuse of alcohol or illicit drugs~* Use of more than one headache prophylactic medication, or change in type and dose of prophylactic medication \< 28 days before start of baseline period~* Previous exposure at any time to any botulinum toxin serotype~* Infection at one or more injection site(s)~* Having received extracranial nerve block, cervical facet injection, or other interventional procedure for headache within the prior 3 months~* Use of opioids or barbiturate containing medication(s) \> 10 days per month within the preceding 3 months~* Participating in another trial that might affect the current study~* Should not participate in the opinion of the investigator (e.g. not able to comply with study procedures).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- BoNT-A injected (Type: EXPERIMENTAL): BoNT-A (Botulinum toxin A) injected in the head on specific sites and in half the usual concentration

Based on this trial design, predict the completion outcome and termination type (if applicable).